The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Cleveland, United States
11-50 Employees
2010
Our line of bioinstrumentation products includes physiological monitors and patient-centered diagnostic and therapy systems integrated with wireless, remote, and web-based applications. By working together with our customers, Great Lakes NeuroTechnologies ensures the delivery of high quality products that fit our customers’ clinical and research requirements. Our activities include R&D, engineering, manufacturing, distribution and the export of research systems and medical devices. Our Biomedical Research Team includes PhDs from some of the nation’s leading educational institutions. Our BioRadio provides a compact, user-worn, and wireless solution to capture various signals. Lab Course, which also uses the BioRadio, provides student laboratory education for both physiology and engineering. Great Lakes NeuroTechnologies is committed to providing high quality and innovative equipment to fulfill your laboratory data acquisition needs. GLNT is committed to customer satisfaction by identifying, communicating, promoting, and fulfilling the needs of our customers.
+
Featured
Great Lakes NeuroTechnologies
... Great Lakes NeuroTechnologies receives UKCA mark for KinesiaU™ motor assessment ...
Berlin, Germany
1-10 Employees
Neuromotion Ventures operates as a venture-building studio, support network, and corporate partner to exceptional founders building software, hardware, and new businesses across neuroscience, wellness, and medical neurotechnology. Productivity and welfare through brain activity-driven light stimulation.
+
Featured
Neurotechnology for better welfare and better healthcare.
... Neuromotion Ventures - Neurotechnology for better welfare and better healthcare. ...
Oud-Heverlee, Belgium
1-10 Employees
2019
We are using implants with thousands of microelectrodes and advanced stimulation algorithms to directly transmit video images to the visual cortex of the brain. We focus on developing a neural implant that can restore practically useful vision in almost all cases of blindness. With our long-standing expertise in flexible brain mplants which have already been verified in several animal models, we are keen on changing the lives of many blind people. Founded in 2019, our history is short but many significant achievements could be made. Who is helping us to achieve our goal and how you could become one of them?
+
Featured
Breakthrough neurotechnology for blind people
... Breakthrough neurotechnology for blind ...
Budapest, Hungary
1-10 Employees
1984
Polaritas is a four-time consecutive supplier of the Olympic Games. Új megoldás, hogy az általunk kifejlesztett egycsatornás elektród hegyi kontaktusán kívül agyi elektromos aktivitást elvezető mikrokontaktusokat integrálunk az elektród vázának oldalába (8-16-32 db), olyan technológiával, ami nem növeli meg szignifikánsan az elektród mostani vastagságát.A kifejlesztett multielektróddal, a létrehozott adatfelvevő hardverrel és megjelenítő szoftverrel olyan csúcstechnológiát hoztunk létre, amely teljes megoldást ad a vásárlók kezébe.
+
Featured
Polaritas | Sports- and Neurotechnology
... Equipped with decades of experience in research and development Polaritas is driving innovation in sports- and neurotechnology. ...
Madrid, Spain
1-10 Employees
2021
We are developing new tools to diagnose and address anxiety disorders.
+
Featured
Home - Dendron Neurotechnologies
... Home - Dendron Neurotechnologies ...
London, United Kingdom
1-10 Employees
2021
That’s why we are forging a new path, one that is grounded in research, neuroscience and the lived experiences of people. We are in the process of developing clinical-grade medical technologies designed to alleviate various symptoms commonly experienced during the fourth trimester. We are in the process of developing clinical-grade medical technologies designed to alleviate various symptoms commonly experienced during menopause. Be the first to hear about product launches. Samphire Neuroscience is a neurotechnology company dedicated to maximising wellbeing of historically underserved communities by delivering pioneering neurotechnology and evidence-based solutions for natural menstrual relief. We have built the world's first Menstrual Neuromodulation Therapy (MNT) via our proprietary headband, Nettle.
+
Featured
Samphire Neuroscience | Neurotechnology for Women
... Samphire Neuroscience is a neurotechnology company dedicated to maximising the well-being of women during menstruation, fourth trimester, and ...
Derry, Ireland
1-10 Employees
2016
Damien Coyle, NeuroCONCISE’s Founder and CEO, is a Professor of Neurotechnology and has published over 150 papers, including contributions to studies in AI-based technologies in brain computer interfaces. NeuroCONCISE works in partnership with Ulster University’s Intelligent Systems Research Centre, The Northern Ireland Functional Brain Mapping Facility and the Spatial Computing and Neurotechnology Innovation Hub and has a steady flow of new intellectual property and expertise contributing to improving the technology. NeuroCONCISE technology is built on multiple-award-winning research, including two international AI awards, nomination for the BCI Award in 2015 and winner of the overall inaugural IET and E&T Innovation of the Year Award 2018. NeuroCONCISE is creating something special that could change the way we assess patients with brain injury and offer rehabilitation to stroke survivors. NeuroCONCISE is part of something bigger, something genuinely important. NeuroCONCISE doesn’t just provide revolutionary hardware, but also a suite of innovative, AI-driven software developed in partnership with Ulster University’s Intelligent Systems Research Centre and Spatial Computing and Neurotechnology Innovation Hub (SCANi-hub). NeuroCONCISE’s research programmes and clinical trials are establishing a revolutionary way to research, assess, and understand consciousness and awareness, targeting clinical assessment and diagnosis following brain injury, augmentative and assistive communications devices and rehabilitation. NeuroCONCISE research shows that our technology may enable users to realise movement independent communication channels and technology interaction, even after experiencing a traumatic brain injury or being unable to speak or move due to disease or injury.
+
Featured
Our Neurotechnology Platform
... Innovative and stylish wearable neurotechnology for brainwave measurement and analysis. Neurotechnology, Biotechnology, Brain-Computer Interfacing, BCI, Flex EEG, EEG, Clinical Trials, Clinical Assessment Tools, Machine Learning, Prolonged Disorders of Consciousness Research, ...
Farmington, United States
1-10 Employees
1998
We are developing a prescription medical device and digital therapeutic that work together to restore healthy brain function in patients with Mild Cognitive Impairment and Alzheimer’s disease. We live in a culture where we are taught that pills are our first line of defense for our ailments. Large founded Oscillo Biosciences to develop treatments for neurodegenerative diseases using the science of music and brain wave stimulation. We’re on a mission to improve the lives of millions of people suffering from devastating diseases and disorders of the central nervous system. Oscillo Biosciences is developing medical devices and digital therapeutic platforms that offer hope to those suffering from neurodegenerative diseases and disorders like Alzheimer’s disease, Parkinson’s, aphasia, dyslexia and others. Among the top 10 causes of death, it is the only one for which there is no known cure.
+
Featured
Treating Disease with Neurotechnology
... Treating Disease with Neurotechnology | Oscillo ...
+
Featured
SensorStim Neurotechnology GmbH
... SensorStim Neurotechnology ...
Palo Alto, United States
2016
NTI offers an investment vehicle for physicians who are in a position to evaluate the probable success of novel technologies and allows them to invest together as a group without the standard trappings of typical investment funds.
+
Featured
The MD Advantage – by NeuroTechnology Investors
... The MD Advantage – by NeuroTechnology ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Neurotechnology
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 45 |
| Amount of suitable service providers | 28 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 1984 |
| Youngest suiting company | 2021 |
20%
40%
60%
80%
Neurotechnology encompasses a broad range of multidisciplinary technologies that interface with the nervous system, including the brain and peripheral nerves, to monitor, understand, or manipulate neural function. At its core, neurotechnology aims to translate the complex language of the nervous system into actionable insights and interventions that can enhance human capabilities or address neurological challenges. This field combines advances in neuroscience, bioengineering, computational science, and nanotechnology, among others, to develop tools and devices such as brain-computer interfaces (BCIs), neural prosthetics, neuroimaging systems, and neuromodulation devices. The impact of neurotechnology within its field is profound, offering revolutionary approaches to the treatment of neurological disorders, rehabilitation from brain injuries, and the enhancement of cognitive functions. It opens new frontiers in understanding brain function, enabling the decoding of neural circuits and the potential to modify or control them in precise ways. By doing so, neurotechnology holds the promise of significant advancements in medical care, improving the quality of life for individuals with neurological conditions, and paving the way for innovative applications in areas ranging from medicine and education to security and entertainment. As this technology continues to evolve, it challenges existing ethical, legal, and social frameworks, necessitating a multidisciplinary approach to its development and implementation.
1. Enhanced Precision in Medical Treatment:
Neurotechnology, through advanced imaging and stimulation techniques, allows for more precise diagnosis and treatment of neurological disorders. This precision surpasses traditional methods, enabling targeted therapies that can improve patient outcomes with fewer side effects.
2. Improved Rehabilitation Processes:
Neurotechnology facilitates the development of innovative rehabilitation tools, such as brain-computer interfaces (BCIs) and virtual reality, which have shown to significantly enhance the recovery process for stroke victims and individuals with motor disabilities. These tools offer personalized rehabilitation, adapting in real-time to the user's progress.
3. Deeper Understanding of the Brain:
The application of neurotechnology provides unparalleled insights into the functioning of the human brain. This deeper understanding helps scientists and medical professionals develop new treatments for brain-related illnesses, improving the quality of life for individuals with mental health issues, neurological disorders, and cognitive impairments.
4. Non-Invasive Options:
Many neurotechnology applications are non-invasive, offering a safer alternative to traditional surgical interventions. Non-invasive brain stimulation techniques, for example, can modulate neuronal activity without the risks associated with surgery, making it an attractive option for patients and clinicians alike.
While evaluating the different suppliers make sure to check the following criteria:
1. Technological Expertise and Innovation
Seek suppliers with a strong track record in neurotechnology, showcasing their ability to innovate and adapt to new scientific discoveries and technological advancements.
2. Quality Assurance and Certifications
Ensure the supplier has rigorous quality control processes in place and holds relevant certifications, indicating their commitment to high standards in product development and safety.
3. Data Security and Privacy Compliance
Given the sensitive nature of neurotechnology products, prioritize suppliers that adhere to stringent data protection regulations and ethical standards to safeguard user information.
4. Scalability and Flexibility
Choose a supplier capable of scaling production to meet demand fluctuations without compromising on quality or delivery times, and who is willing to adapt products to your specific needs.
5. Customer Support and After-Sales Service
Look for suppliers that offer comprehensive support, including training, maintenance, and troubleshooting, ensuring you can maximize the value of your investment.
6. Cost-Effectiveness
While not compromising on quality, consider the overall cost-effectiveness of the supplier's offerings, including initial investment, maintenance, and potential for long-term savings.
7. Collaborative Potential
Select suppliers interested in forming partnerships, willing to collaborate on future projects, and receptive to feedback for continuous improvement of their products and services.
Neurotechnology, with its ability to understand, simulate, and enhance brain function, finds application across various industries, significantly transforming how businesses operate. In the healthcare sector, it's revolutionizing patient care through advanced diagnostics and therapeutic tools. Brain-computer interfaces (BCIs) enable patients with paralysis to control prosthetic limbs or communicate, providing a new lease on life and reducing long-term care costs. This technology not only improves patient outcomes but also opens new markets for medical device manufacturers and healthcare providers. In the realm of marketing and consumer research, companies leverage neurotechnology to gain deeper insights into consumer behavior and preferences. By analyzing neural responses to products or advertisements, businesses can tailor their offerings and marketing strategies more effectively, enhancing customer engagement and optimizing marketing spend. This approach leads to more personalized consumer experiences and improved product development, based on real, subconscious consumer reactions. Additionally, the field of workforce development and training is being transformed by neurotechnology. Through neuro-enhancement tools and brain training programs, businesses can improve employee productivity, creativity, and well-being. These technologies can reduce stress, enhance focus, and improve cognitive functions, leading to a more efficient and satisfied workforce. This not only improves individual performance but also offers companies a competitive edge in talent development and retention. In summary, neurotechnology is creating value across various industries by enhancing healthcare outcomes, providing deeper consumer insights, and improving workforce efficiency and satisfaction. Its diverse applications demonstrate the vast potential of this technology to solve complex challenges and drive business innovation.
Neurotechnology, encompassing a broad range of technologies designed to understand, repair, enhance, or exploit the properties of the nervous system, currently spans multiple Technology Readiness Levels (TRLs), but a significant portion of its applications are at TRL 4 to TRL 6. This range indicates that neurotechnological innovations, such as brain-computer interfaces (BCIs), neuroprosthetics, and neural recording devices, have progressed from laboratory research (TRL 4) to proof-of-concept validation in relevant environments (TRL 5) and are advancing towards demonstration in operational environments (TRL 6). This positioning is due to several technical reasons. Firstly, the complexity of the human nervous system presents a significant challenge, requiring sophisticated methodologies for accurate signal detection, decoding, and modulation. Advances in materials science and microfabrication have facilitated the development of more biocompatible and efficient neural interfaces, moving the field forward. Secondly, computational algorithms for processing neural data have become more refined, enabling more accurate interpretation and response to neural signals, thus pushing certain applications into more advanced TRLs. However, the translation from controlled settings to real-world applications faces hurdles such as ensuring long-term device stability, safety, and ethical considerations, which are critical for advancing to higher TRLs. These technical challenges underscore the multidisciplinary effort required to elevate neurotechnology to widespread clinical and consumer use.
In the Short-Term phase, neurotechnology is poised to see significant advancements in brain-computer interfaces (BCIs) and neuroprosthetics. This period will likely witness the refinement of non-invasive BCIs, allowing for more sophisticated communication between the human brain and computers, enhancing assistive technologies for individuals with disabilities. Additionally, there will be an increased focus on developing more precise and less obtrusive neuroprosthetic devices, aimed at improving the quality of life for those with limb losses, by offering better control and sensory feedback. Mid-Term advancements will be characterized by the integration of artificial intelligence (AI) with neurotechnology to decode complex neural patterns and predict neurological issues before they become severe. This phase will also see the emergence of personalized neurotechnology, leveraging genetic information to tailor treatments for neurological disorders. Enhanced neuroimaging techniques will emerge, offering deeper insights into the brain's functioning and facilitating the early diagnosis of conditions like Alzheimer's and depression. This period could also introduce the initial stages of neural augmentation, potentially enhancing cognitive functions. In the Long-Term, neurotechnology is expected to break new ground in fully integrating human cognition with artificial intelligence, leading to unprecedented levels of brain enhancement and machine symbiosis. Neural augmentation will likely become more refined and widely accessible, significantly boosting memory, learning capabilities, and even creating new senses or enhancing existing ones. Ethical and safety frameworks will be crucial as these technologies mature, ensuring they benefit humanity while minimizing risks of misuse. This era could also witness the realization of collective consciousness through advanced BCIs, enabling shared human experiences and knowledge on a scale never before seen.
Some interesting questions that has been asked about the results you have just received for Neurotechnology
What are related technologies to Neurotechnology?
Based on our calculations related technologies to Neurotechnology are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Neurotechnology?
Which industries are mostly working on Neurotechnology?
The most represented industries which are working in Neurotechnology are Health Care, Biotechnology, Information Technology, Science and Engineering, Hardware
How does ensun find these Neurotechnology Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
